• Nenhum resultado encontrado

[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.39 número1

Has 10000 "Rev. Bras. Hematol. Hemoter. vol.39 número1" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.39 número1".

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... This is a cheap drug used in the treatment of CLL that could improve the lives of thousands of SUS patients and those insured by health care providers.. Another paradox exists in the cas[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Immunophenotyping by FC of BM cells showed the presence of clonal plasma cells (40%) expressing CD38, CD138 dim , cy kappa , smkappa, ␤-2 microglobulin and CD81, and were negative for CD[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... induction or consolidation. Six patients out of 45 (13%) pre- sented molecular (three) or hematologic (three) relapse. The first relapse among the patients occurred at a median of 39 months (range: 21–48 months) ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... The dilution technique of patient’s serum is found to be a good alternative to ZZAP or PEG adsorption for detec- ting underlying alloantibodies in patients with autoantibodies with mimic[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Primary breast lymphoma (PBL) is a clinicopathological entity characterized by the appearance of a unilateral breast mass of months of evolution, infrequently accompanied by signs of ski[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Because of the aforementioned ATRA handling problems, we have seen dose administration delays, unaware nursing technicians trying to manipulate ATRA (some of them in the fertile age) and[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... A hemophilic pseudotumor is the result of repeated episodes of bleeding at a bone fracture site or as a result of sub-periosteal hemorrhage or bleeding into soft tissue due to absence or[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... 3 When the molecular basis of the disease cannot be identified in this way, multiplex ligation-dependent probe amplification (MLPA) can be used to detect new or rare deletions in the ␣ g[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leuke[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Alternating courses of 3x CHOP and 3x DHAP plus rituximab followed by a high dose ARA-C containing myeloablative regimen and autologous stem cell transplantation (ASCT) increases overall[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Although the few reported cutaneous histologic features are mostly those of sarcoid-type non-caseating granulomas, other features, such as tuberculoid and palisaded granulomas, have been[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... HPLC analysis was performed using an in-house method employing an ultra-speed HPLC system with a 415 nm UV/VIS- Detector (Shimadzu Corp., Japan).. The method to obtain a Hb chromatogram [r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... A fecal sample obtained during an outpatient visit on D + 27 was positive for HAdV (6.94 × 10 10 copies/mL) and for norovirus (GI.3); at the time the patient presented with diarrhea, abd[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... 2. Forester CM, Sartain SE, Guo D, Harris MH, Weinberg OK, Fleming MD, et al. Pediatric aplastic anemia and refractory cytopenia: a retrospective analysis assessing outcomes and histomorphologic predictors. Am J ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Survival of children with sickle cell disease in the comprehensive newborn screening programme in Minas Gerais, Brazil. Paediatr Int Child Health[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Among hematological variables only hemoglobin and hematocrit levels were statistically different between patients treated with hydroxyurea and untreated patients ( p -value = 0.005 and p[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... The findings of the present study show that individuals with SCD and a history of stroke have poorer IQ scores and abnor- malities in attention and executive functioning, language, verba[r] ... See full document

8

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... This study showed that a prevalence of 25.2% of gallstones was observed in patients with sickle cell disease and 11- to 29-year-old patients have a higher incidence of gallstones.. So, p[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... The response of one patient, who received 320 mg/kg SAN- GUINATE, of multi-day increases in TRV to levels typically associated with moderate-to-severe pulmonary hypertension, substantial[r] ... See full document

8

Rev. Bras. Hematol. Hemoter.  vol.39 número1

Rev. Bras. Hematol. Hemoter. vol.39 número1

... Complete response was achieved in seven smoldering patients with symptomatic treatment, in two favorable chronic patients (one treated with antiviral therapy alone and one with chemother[r] ... See full document

7

Show all 10000 documents...